Vaginal or Vulvar Itching During Menopause: Dryness, Skin Conditions, Infection, and Next Steps

Start with the location, not the life-stage label

The vulva is the external genital area around the vaginal opening. It includes skin that can be affected by friction, detergents, fragranced products, inflammatory skin conditions, and local injury. Symptoms described as “vaginal itching” may actually be on the vulva, inside the vagina, or in both places. 4 11

External symptoms may include itch, burning, soreness, fragile skin, color or texture changes, cracks, white patches, or a focal sore. Internal vaginal symptoms may be described as dryness, burning, discomfort with penetration, or a change in discharge. Urinary burning, urgency, or frequency adds another route. Locating the symptom helps organize the assessment, but location alone still does not determine the cause.

When menopause-related tissue change is plausible

Lower estrogen can contribute to thinner and drier vaginal tissues. GSM can include genital and urinary symptoms during and after the menopausal transition. Current multidisciplinary guidance emphasizes that diagnosis requires considering other or coexisting causes rather than assuming that age and dryness explain the presentation. 1 2

A dryness pattern may include reduced lubrication, irritation, burning, or pain with sexual activity. Urinary urgency, frequency, or discomfort may occur in the same life stage. Those features can fit GSM, but they can also overlap infection, irritation, pelvic-floor problems, urinary disease, or vulvar skin conditions. A website cannot make that distinction from a symptom list. 1 3 10 11

The practical rule is to treat “menopause” as a clue about context, not as a label that closes the differential.

Irritation and contact exposure remain possible

Scented washes, wipes, sprays, detergents, fabric products, repeated washing, heat, moisture, and rubbing can aggravate vulvar skin. A product does not have to be new to be relevant; sensitivity can develop after a period of previous tolerance. Improvement after stopping an exposure may strengthen the history, but it does not identify an allergen or prove that no other condition is present. 2 4

While symptoms are being sorted out, avoid douching and avoid putting ordinary body creams or lotions inside the vagina. External skin care and intravaginal product use are different routes. A product intended for one location should not be moved to another simply because the label uses broad “intimate care” language. 3 11

Persistent or worsening symptoms should not trigger a cycle of adding more fragranced or active products. Repeated product switching can obscure the pattern and may add irritation.

Yeast and other vaginal causes cannot be diagnosed by itch alone

Vulvovaginal candidiasis can cause itching, soreness, external urinary burning, and discharge, but those symptoms are not specific to yeast. Finding Candida without relevant signs or symptoms also does not automatically establish a condition that needs treatment. 8

A previous yeast diagnosis does not prove that a new episode is the same. CDC guidance recommends evaluation and testing when symptoms persist after an over-the-counter yeast treatment or recur within less than two months. That interval is not a rule to wait when there is pain, bleeding, a sore, pregnancy, fever, or another warning sign. 8

Bacterial vaginosis, trichomoniasis, other infections, irritation, and hormonal changes can overlap. Vaginal pH may contribute information, but pH alone does not diagnose bacterial vaginosis or identify the cause of itching. Clinical criteria and appropriately selected tests provide additional context. 9 11

Menopause also does not eliminate the possibility of acquiring an STI. Exposure history and symptoms, not age alone, determine whether sexual-health testing should be considered. 12

External white patches, fragile skin, sores, or lumps need examination

Lichen sclerosus is one example of an inflammatory condition that can affect genital skin. It may cause itchy, white, fragile patches, cracking, or scarring. Those features are reasons for examination, not a reliable self-diagnostic pattern. 5

Persistent vulvar sores, ulcers, lumps, bleeding, or changes in skin color or texture also deserve assessment. Such findings can have many noncancerous causes, but uncertainty is not a reason to ignore them or repeatedly cover them with presumed yeast or dryness treatments. 5 7

A photograph cannot reliably distinguish lichen sclerosus, infection, irritation, precancerous change, or another disorder. An external examination, and sometimes additional testing or biopsy when clinically appropriate, may be needed. 4 5

Bleeding after menopause is a separate decision route

Bleeding after menopause should be assessed even if it happens only once, appears only as spotting, or follows sex. Thinner tissue or friction can be one possible explanation, but polyps, endometrial changes, cancer, and other causes are also possible. The cause should not be assumed from the amount or timing of bleeding. 6 7

This does not mean every small, stable episode of spotting automatically requires an emergency department or proves cancer. It means a moisturizer trial should not be used as a prerequisite for evaluation. Heavy bleeding, faintness, severe pain, or rapid deterioration changes the urgency.

Urinary symptoms may overlap, but systemic signs matter

Burning with urination, urgency, or frequency can occur around menopause, but they should not automatically be attributed to GSM. A urinary infection or another urinary condition may need assessment. 1 10

Fever, shivering, pain in the side or back, or visible blood in the urine increases concern for a urinary infection that needs urgent assessment. Acute confusion, marked drowsiness, or difficulty speaking is an emergency pattern, not a dryness symptom to manage with a product comparison. 10

Moisturizers and lubricants answer narrower questions

A lubricant is generally used to reduce friction during sexual activity. A vaginal moisturizer is used to support moisture over time. Either may help some dryness-related symptoms, but neither establishes why the symptoms are occurring. 3 12

For exact formulation, route, ingredients, use pattern, and condom-material compatibility, see vaginal moisturizers for menopause. That comparison does not diagnose the cause of symptoms.

Persistent irritation, unusual discharge, pain, urinary symptoms, bleeding, or visible skin change should not be managed by moving endlessly from one product to another.

Local vaginal estrogen and systemic hormone therapy are not interchangeable

Local vaginal estrogen and systemic menopausal hormone therapy are different treatment decisions. Nonhormonal moisturizers and lubricants are also separate categories. Current guidance emphasizes shared decision-making that considers evidence, adverse effects, individual goals, and preferences. 1 2 12

This page does not select a hormone product, dose, route, or sequence. Decisions involving a history of estrogen-sensitive cancer, current endocrine therapy, unexplained bleeding, or other significant medical factors require dedicated evidence and individualized review rather than a blanket statement that hormones are always safe or always prohibited.

What an assessment may involve

Depending on the symptoms, assessment may include a review of products and medicines, inspection of the external vulvar skin, a pelvic examination, and selected swabs or urine tests. Not every person needs every test. 4 11

Consent remains active throughout an examination. A patient can ask what is being done, request a pause, or ask for the examination to stop. That right does not depend on whether the symptom is believed to be hormonal, infectious, or dermatologic. 11

When to seek assessment

Arrange assessment when symptoms are persistent, recurrent, worsening, affecting daily life, or accompanied by unusual discharge, urinary symptoms, pain during sex, or a possible STI exposure. Reassessment is also appropriate after an unsuccessful over-the-counter yeast treatment rather than continuing repeated empirical treatment. 3 8 11 12

Do not delay assessment for bleeding after menopause, a persistent sore, lump, ulcer, or skin change. Seek urgent assessment for urinary symptoms with fever, shivering, flank or back pain, or visible blood in the urine. Acute confusion, marked drowsiness, difficulty speaking, severe pain, faintness, heavy bleeding, or rapidly worsening illness requires emergency evaluation. 5 6 7 10

Related guides

• Itching, dryness, and bleeding after menopause
• Vulvar lichen sclerosus and itching
• Vaginal or vulvar itching during perimenopause
• Lubricants for vaginal dryness

Bottom line

Menopause can contribute to vaginal dryness and to genital or urinary symptoms, but it does not explain every itch. Separate external vulvar skin symptoms from internal vaginal discomfort, keep infection and skin disease visible, and treat bleeding after menopause as a reason for assessment rather than as proof of simple friction.

Moisturizers, lubricants, local vaginal estrogen, and systemic hormone therapy answer different treatment questions. None should be used to bypass evaluation of persistent symptoms, urinary warning signs, focal skin changes, sores, or postmenopausal bleeding.